VSee Health, Inc. Interest Expense Nonoperating
VSee Health, Inc. (VSEE) reported Interest Expense Nonoperating of $80.70 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- VSee Health, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $80.70K, a 63.71% decline year-over-year.
- VSee Health, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $113.10K, a 84.52% decline year-over-year.
- VSee Health, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $1.08M.
- VSee Health, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $755.87K, a 555.08% increase year-over-year.
- VSee Health, Inc. interest expense nonoperating for fiscal 2025 was $2.81M, a 1229.74% increase from fiscal 2024.
- VSee Health, Inc. interest expense nonoperating for fiscal 2024 was $211.46K, a 10.52% increase from fiscal 2023.
- VSee Health, Inc. interest expense nonoperating for fiscal 2023 was $191.32K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 9 month as first filed | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $80.70K 10-Q · filed 2026-08-14 | $172.64K 10-Q · filed 2026-08-14 | $1.28M derived: sum of 3 quarters · filed 2026-08-14 | $2.03M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $113.10K 10-Q · filed 2026-05-15 | $1.20M derived: sum of 2 quarters · filed 2026-05-15 | $1.95M derived: sum of 3 quarters · filed 2026-05-15 | $2.18M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.84M derived: sum of 2 quarters · filed 2026-03-31 | $2.06M derived: sum of 3 quarters · filed 2026-08-14 | $2.81M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $755.87K 10-Q · filed 2025-11-14 | $978.23K derived: sum of 2 quarters · filed 2026-08-14 | $1.73M 10-Q · filed 2025-11-14 | $1.45M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $222.36K 10-Q · filed 2026-08-14 | $240.58K 10-Q · filed 2025-10-15 | $916.97K 10-Q · filed 2026-08-14 | $971.24K 10-Q · filed 2025-10-15 | $697.96K derived: sum of 3 quarters · filed 2026-08-14 | $813.34K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $730.66K 10-Q · filed 2026-05-15 | $475.59K derived: sum of 2 quarters · filed 2026-05-15 | $590.98K derived: sum of 3 quarters · filed 2026-05-15 | $932.81K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$255.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$139.69K derived: sum of 2 quarters · filed 2026-03-31 | $202.15K derived: sum of 3 quarters · filed 2026-03-31 | $211.46K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $115.39K 10-Q · filed 2025-11-14 | $232.08K 10-Q · filed 2024-11-14 | $457.22K derived: sum of 2 quarters · filed 2025-11-20 | $466.53K 10-Q · filed 2025-11-14 | $591.09K 10-Q · filed 2024-11-14 | $494.28K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-06-30 | $341.83K 10-Q/A · filed 2025-11-20 | $349.69K 10-Q · filed 2024-09-23 | $351.14K 10-Q/A · filed 2025-11-20 | $359.00K 10-Q · filed 2024-09-23 | $378.89K derived: sum of 3 quarters · filed 2025-11-20 | $415.21K derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-03-31 | $9.31K 10-Q · filed 2025-10-15 | $37.06K derived: sum of 2 quarters · filed 2025-10-15 | $73.37K derived: sum of 3 quarters · filed 2025-10-15 | $153.23K derived: sum of 4 quarters · filed 2025-10-15 | |||
| 2023-12-31 | $27.75K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $64.06K derived: sum of 2 quarters · filed 2025-08-29 | $143.92K derived: sum of 3 quarters · filed 2025-08-29 | $191.32K 10-K/A · filed 2025-08-29 | |||
| 2023-09-30 | $36.31K 10-Q · filed 2024-11-14 | $116.17K derived: sum of 2 quarters · filed 2024-11-14 | $163.57K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $79.86K 10-Q · filed 2024-09-23 | $127.26K 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |